logo
Woman says dog detected her breast cancer before doctors did: 'He's known this whole time'

Woman says dog detected her breast cancer before doctors did: 'He's known this whole time'

Fox News26-04-2025

Breanna Bortner says her dog had a hand — or a paw — in saving her life.
"I had always heard stories where people, you know, say that their dogs could sense things," the Minnesota woman, now 31, told Fox News Digital during an on-camera interview. (See the video at the top of the article.)
In 2023, Bortner — who now runs the blog "Brave Beautiful Boobies" documenting her experience — discovered a lump in her breast.
There were about six weeks between the discovery of the lump and the biopsy, she recalled.
During this time, Bortner's cockapoo, Mochi, became fixated on the breast with the lump. The behavior came as a surprise to Bortner, who said the dog had never behaved that way before.
"Even when I had been sick in the past or dealt with other things, he had never done that, so that was the first time that I really noticed how in tune he was to my body," she said.
The results of the biopsy soon confirmed that Bortner had breast cancer — but she said she already knew, courtesy of Mochi.
"I was like, oh my gosh, he's known this whole time. Before I knew and the doctors knew."
Doctors diagnosed Bortner with stage 2B triple-negative invasive ductal carcinoma, a type of breast cancer that has fewer treatment options than other types of invasive breast cancer, according to the American Cancer Society.
This is because these cancer cells do not have certain receptors that allow them to be treated with hormone therapy.
"If the cancer has not spread to distant sites, surgery is an option. Chemotherapy might be given first to shrink a large tumor, followed by surgery," reads the ACS website.
After doctors confirmed the cancer, Bortner said the process moved very quickly. She underwent five-and-a-half months of chemotherapy (16 rounds total).
"Chemotherapy is a very scary, daunting word," she said. "Everything about [chemotherapy drugs] is scary. I found that calling them 'healing sessions' instead of chemotherapy was better for me."
Bortner said that Mochi, who she calls her "soul dog," continued to be a source of comfort — and a reason to keep going in those dark days.
"At the time, he was only 2 years old," she said.
"And I was like, 'I cannot leave this earth before you do.' Like, no way. 'I should be the one burying you. You shouldn't be the one having to lose your human mom.'"
Tasks as mundane as feeding the dog or taking him on a walk helped Bortner get off the couch and keep going.
Mochi learned to adapt to Bortner's new lifestyle during recovery, as their walks were slower and shorter.
When Bortner would nap for long periods or sometimes cry, the dog was always there to comfort her, she shared.
When she left for appointments — sometimes multiple times per day — Mochi would dig through the trash to collect his owner's hair, which was falling out at the time due to chemotherapy.
"He would dig out my hair to smell me," Bortner said.
Even now, with Bortner almost a year out of cancer treatment, Mochi still digs through the trash out of habit.
Today, Bortner provides support to others going through the same experience, serving as a source of information about what to expect and how to keep going.
"It just brings a smile to my face when things come full circle — and now I'm on the other end, mentoring people through their cancer journeys," she said.
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, confirmed that dogs have an "exquisite sense of smell."
"There is evidence in the medical literature that they can in fact smell the abnormal cancer proteins," the doctor told Fox News Digital.
"In fact, artificial canine noses have been created relying on this response. Artificial intelligence is now enhancing this ability."
Pashtoon Kasi, M.D., medical director of gastrointestinal medical oncology at City of Hope in Orange County, California, was also not surprised by the idea that dogs could detect molecules or byproducts from cancer.
"There is a lot of information that can be non-invasively found in blood, urine or other bodily fluids — or even the breath of individuals who have cancer in their bodies," he told Fox News Digital.
"It has been demonstrated that dogs, and potentially other animals, are likely able to detect some of the odors associated with certain chemicals linked to cancer, which are detected in the blood or bodily fluids of patients with cancer."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2025 Cattle Baron's Ball raises money for cancer research in Tyler
2025 Cattle Baron's Ball raises money for cancer research in Tyler

Yahoo

timea day ago

  • Yahoo

2025 Cattle Baron's Ball raises money for cancer research in Tyler

TYLER, Texas (KETK) – The annual Cattle Baron's Ball was held at the Texas Rose Horse Park on Saturday as a way to benefit the American Cancer Society's work to end cancer. UT Tyler gets $441K grant to develop cancer-targeting nanotechnology The 'toe-tapping, knee-slapping' event featured food, drinks, dancing, an auction and raffle tickets, all supporting the American Cancer Society. 'The American Cancer Society is working to end cancer as we know it, for everyone. We are the largest private, not-for-profit funder of cancer research in the United States, investing more than $4 billion since 1946,' the American Cancer Society said. 'Thanks in part to our contributions, more than 1.5 million lives have been saved in the US in the past two decades. Now, that is a reason to celebrate!' According to the American Cancer Society's website, this year's mission with the Cattle Baron's Ball is to raise money for breast cancer research and to help provide access to cancer care across Texas by providing grants to cover transportation and lodging costs in Texas health systems. To learn more, visit the Cattle Baron's Ball online. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

American Cancer Society raises $400,000 with Walk & Roll event
American Cancer Society raises $400,000 with Walk & Roll event

Yahoo

timea day ago

  • Yahoo

American Cancer Society raises $400,000 with Walk & Roll event

CHICAGO – It was time to walk and roll Saturday morning! In Grant Park, 1,500 people worked up a sweat to raise money for the American Cancer Society in its 54th year. 'Walk and Roll' is the longest-running cancer fundraiser in Illinois. Participants had their choice of biking, skating, running or walking. Exercise may stop colon cancer from returning — and more 'We see people along the lakefront every day walking, running, biking, skating, so why not raise money for cancer research for that? We love to have survivors and caregivers out here. They're definitely the faces of what we do every day,' Jody Phillips of the American Cancer Society said. Cancer survivors include WGN-TV reporter Mike Lowe as well as motivational speaker and author Randi Moxi. 'I was diagnosed with colorectal cancer just about a year ago, and after a year of radiation and chemo therapy and treatment, I'm standing here today with the cancer undetectable,' Lowe said. Read more: Latest Chicago news and headlines 'It is overwhelming. It's beautiful. It's wonderful, and I think together we're going to make a huge difference and eventually get to an end of this nonsense,' Moxi added. The $400,000 raised during the event alone helps pay for research and patient care programs. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Psychedelics as potential mental health treatment are explored by Trump administration
Psychedelics as potential mental health treatment are explored by Trump administration

Yahoo

timea day ago

  • Yahoo

Psychedelics as potential mental health treatment are explored by Trump administration

The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store